-
D. Boral Capital Reiterates "Buy" Rating for UroGen Pharma (NASDAQ:URGN)
Source: Buzz FX / 19 Feb 2025 07:16:13 America/Chicago
D. Boral Capital Reiterates "Buy" Rating for UroGen Pharma (NASDAQ:URGN) Written by MarketBeat February 19, 2025 Share Link copied to clipboard. UroGen Pharma ( NASDAQ:URGN - Get Free Report ) 's stock had its "buy" rating reiterated by equ
Read more...